Pancreatic Cancer Research

ResearcherKorea Research Institute of Bioscience and BiotechnologyNo recent work listed

Seokho Kim

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5112400540. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper

Papers 4

  1. An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model. Last author DOI 10.1158/2326-6066.cir-18-0317↗
  2. Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer. Co-author DOI 10.1038/s41598-018-30582-8↗
  3. Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4. Co-author DOI 10.18632/oncotarget.4859↗
  4. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. First author DOI 10.1093/carcin/bgs378↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tae Heung Kang · 3 shared papers, 2015–2019 · strength 0.21
  2. Sang Seok Koh · 3 shared papers, 2013–2018 · strength 0.16
  3. Wonbeak Yoo · 1 shared paper, 2019 · strength 0.09
  4. Jae Min Lee · 1 shared paper, 2019 · strength 0.09
  5. Jae‐Hoon Kim · 1 shared paper, 2018 · strength 0.08
  6. Stephen M. Hewitt · 1 shared paper, 2018 · strength 0.08
  7. Chel Hun Choi · 1 shared paper, 2018 · strength 0.08
  8. Yeong-Min Park · 1 shared paper, 2015 · strength 0.04
  9. Si Young Song · 1 shared paper, 2013 · strength 0.04
  10. Eun Hye Park · 1 shared paper, 2013 · strength 0.04
  11. Dong Ki Lee · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.